Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria
Gustavo Deza, Peter A. Ricketti, Ana M. Giménez‐Arnau, et al.
The Journal of Allergy and Clinical Immunology In Practice (2018) Vol. 6, Iss. 4, pp. 1108-1117
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells
Ana M. Giménez‐Arnau, Laurence de Montjoye, Riccardo Asero, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 6, pp. 2195-2208
Open Access | Times Cited: 124
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances
Allen P. Kaplan, Mark Lebwohl, Ana M. Giménez‐Arnau, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 389-401
Open Access | Times Cited: 87
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2
Eli Magen, Avi Yakov, Ilan Green, et al.
Allergy and Asthma Proceedings (2022) Vol. 43, Iss. 1, pp. 30-36
Open Access | Times Cited: 47
How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers
Murat Türk, Leonor Carneiro‐Leão, Pavel Kolkhir, et al.
The Journal of Allergy and Clinical Immunology In Practice (2019) Vol. 8, Iss. 1, pp. 113-124
Closed Access | Times Cited: 70
Urticaria and Angioedema Across the Ages
Sarbjit S. Saini, Marissa Shams, Jonathan A. Bernstein, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 6, pp. 1866-1874
Closed Access | Times Cited: 61
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
Thomas B. Casale, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 11, pp. 2573-2588
Open Access | Times Cited: 17
COVID-19 Disease Leading to Chronic Spontaneous Urticaria Exacerbation: A Romanian Retrospective Study
Ioana Adriana Muntean, Irena Pintea, Ioana Corina Bocșan, et al.
Healthcare (2021) Vol. 9, Iss. 9, pp. 1144-1144
Open Access | Times Cited: 39
Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study
Bastsetseg Ulambayar, Eun‐Mi Yang, Hyun‐Young Cha, et al.
Clinical and Translational Allergy (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution
Gustavo Deza, Álvaro March‐Rodríguez, Sílvia Sánchez, et al.
The Journal of Allergy and Clinical Immunology In Practice (2019) Vol. 7, Iss. 5, pp. 1619-1626.e1
Closed Access | Times Cited: 31
<p>Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications</p>
Ilaria Puxeddu, Fiorella Petrelli, Francesca Angelotti, et al.
Journal of Asthma and Allergy (2019) Vol. Volume 12, pp. 285-295
Open Access | Times Cited: 30
Biomarkers of chronic spontaneous urticaria and their clinical implications
Riccardo Asero, Massimo Cugno
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 3, pp. 247-254
Closed Access | Times Cited: 25
Advanced Biomarkers: Therapeutic and Diagnostic Targets in Urticaria
Yue Zhang, Hanyi Zhang, Shengyi Du, et al.
International Archives of Allergy and Immunology (2021) Vol. 182, Iss. 10, pp. 917-931
Open Access | Times Cited: 24
Advances in drug allergy, urticaria, angioedema, and anaphylaxis in 2018
Rachel L. Miller, Maria Shtessel, Lacey B. Robinson, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 2, pp. 381-392
Open Access | Times Cited: 28
Cytokines and Chemokines Modulation of Itch
Lixia Du, Jianyu Zhu, Wen‐Li Mi
Neuroscience (2022) Vol. 495, pp. 74-85
Closed Access | Times Cited: 14
Key differences between chronic inducible and spontaneous urticaria
Mojca Bizjak, Mitja Košnik
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 2
Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous urticaria - A real-life experience
Ramit Maoz‐Segal, Tanya Levy, Soad Haj Yahia, et al.
World Allergy Organization Journal (2020) Vol. 13, Iss. 8, pp. 100448-100448
Open Access | Times Cited: 17
Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring
Emek Kocatürk, Sarbjit S. Saini, Christine J. Rubeiz, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 12, pp. 3099-3116
Closed Access | Times Cited: 10
Recent updates in urticaria
Ana M. Giménez‐Arnau, Nerea Manzanares, Indrashis Podder
Medicina Clínica (2023) Vol. 161, Iss. 10, pp. 435-444
Closed Access | Times Cited: 6
Sleep disturbance in adults with chronic pruritic dermatoses is associated with increased C-reactive protein levels
Sagar P. Patel, Raveena Khanna, Justin Choi, et al.
Journal of the American Academy of Dermatology (2020) Vol. 84, Iss. 2, pp. 265-272
Closed Access | Times Cited: 15
Biomarkers of disease activity in patients with chronic spontaneous urticaria
Aleksandra Plavšić, Vesna Tomić-Spirić, Snežana Arandjelović, et al.
Advances in Dermatology and Allergology (2021) Vol. 38, Iss. 6, pp. 1017-1022
Open Access | Times Cited: 13
Novel biologics for treatment of chronic spontaneous urticaria
Thomas B. Casale
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 6, pp. 1256-1259
Closed Access | Times Cited: 9
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers
Jonathan J. Lyons, Henriette Farkas, Anastasios E. Germenis, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2286-2301
Open Access | Times Cited: 5
Current perspectives and future directions in the management of chronic spontaneous urticaria and their link to disease pathogenesis and biomarkers
Ana M. Giménez‐Arnau, Indrashis Podder
Italian Journal of Dermatology and Venereology (2023) Vol. 158, Iss. 4
Closed Access | Times Cited: 5
Decoding the Enigma of Urticaria and Angioedema
David P. Huston, Vito Sabato
The Journal of Allergy and Clinical Immunology In Practice (2018) Vol. 6, Iss. 4, pp. 1171-1175
Closed Access | Times Cited: 16
Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs
Satoshi Izaki, Shota Toyoshima, T. Endo, et al.
Allergology International (2019) Vol. 68, Iss. 3, pp. 342-351
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top